These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inhibitory effect of totarol on exotoxin proteins hemolysin and enterotoxins secreted by Staphylococcus aureus. Shi C; Zhao X; Li W; Meng R; Liu Z; Liu M; Guo N; Yu L World J Microbiol Biotechnol; 2015 Oct; 31(10):1565-73. PubMed ID: 26193949 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the effect of α-defensin human neutrophil peptides on neutrophil apoptosis. Nagaoka I; Suzuki K; Murakami T; Niyonsaba F; Tamura H; Hirata M Int J Mol Med; 2010 Dec; 26(6):925-34. PubMed ID: 21042789 [TBL] [Abstract][Full Text] [Related]
27. Specificity in killing pathogens is mediated by distinct repertoires of human neutrophil peptides. Cederlund A; Agerberth B; Bergman P J Innate Immun; 2010; 2(6):508-21. PubMed ID: 20820100 [TBL] [Abstract][Full Text] [Related]
28. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin. Graham S; Coote PJ J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959 [TBL] [Abstract][Full Text] [Related]
29. Human alpha-defensins inhibit Clostridium difficile toxin B. Giesemann T; Guttenberg G; Aktories K Gastroenterology; 2008 Jun; 134(7):2049-58. PubMed ID: 18435932 [TBL] [Abstract][Full Text] [Related]
30. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. Ong PY; Ohtake T; Brandt C; Strickland I; Boguniewicz M; Ganz T; Gallo RL; Leung DY N Engl J Med; 2002 Oct; 347(15):1151-60. PubMed ID: 12374875 [TBL] [Abstract][Full Text] [Related]
31. Antibacterial activity of human defensins against Bolatchiev A PeerJ; 2020; 8():e10455. PubMed ID: 33304659 [TBL] [Abstract][Full Text] [Related]
32. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. Jin T; Bokarewa M; Foster T; Mitchell J; Higgins J; Tarkowski A J Immunol; 2004 Jan; 172(2):1169-76. PubMed ID: 14707093 [TBL] [Abstract][Full Text] [Related]
33. Differential induction of innate defense antimicrobial peptides in primary nasal epithelial cells upon stimulation with inflammatory cytokines, Th17 cytokines or bacterial conditioned medium from Staphylococcus aureus isolates. Burgey C; Kern WV; Römer W; Rieg S Microb Pathog; 2016 Jan; 90():69-77. PubMed ID: 26616165 [TBL] [Abstract][Full Text] [Related]
34. pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37. Abou Alaiwa MH; Reznikov LR; Gansemer ND; Sheets KA; Horswill AR; Stoltz DA; Zabner J; Welsh MJ Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18703-8. PubMed ID: 25512526 [TBL] [Abstract][Full Text] [Related]
35. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. Schlievert PM; Strandberg KL; Lin YC; Peterson ML; Leung DY J Allergy Clin Immunol; 2010 Jan; 125(1):39-49. PubMed ID: 20109735 [TBL] [Abstract][Full Text] [Related]
36. Detection of natural peptide antibiotics in human nasolacrimal ducts. Paulsen FP; Pufe T; Schaudig U; Held-Feindt J; Lehmann J; Schröder JM; Tillmann BN Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2157-63. PubMed ID: 11527925 [TBL] [Abstract][Full Text] [Related]